Endografting of the abdominal aorta and iliac arteries for occlusive disease

Area of Science:

• Vascular Surgery
• Endovascular Interventions
• Atherosclerosis Treatment

Background:

• Short segment obstructions in aorto-iliac occlusive disease are effectively treated with angioplasty and stenting.
• Long-segment, diffuse, or calcific disease often requires surgical bypass, but many patients are high-risk surgical candidates.
• Aorto-iliac endografts are established for aneurysmal disease and are being explored for occlusive conditions.

Purpose of the Study:

• To evaluate the potential of endografting for extensive, end-stage aorto-iliac occlusive disease.
• To improve short and long-term outcomes of endovascular treatment in complex cases.
• To assess the emerging role of endografts in treating challenging aorto-iliac atherosclerosis.

Main Methods:

• Review of early experiences and existing literature on aorto-iliac endografting for occlusive disease.
• Comparison of endografting outcomes with traditional surgical bypass and angioplasty/stenting.
• Identification of the need for prospective clinical trials to validate efficacy.

Main Results:

• Early results with endografts for aorto-iliac occlusive disease are encouraging.
• Current evidence does not yet demonstrate superior long-term patency compared to angioplasty and stenting.
• Endografting offers a less invasive option for high-risk patients unsuitable for open surgery.

Conclusions:

• Aorto-iliac endografts represent a promising endovascular approach for complex aorto-iliac occlusive disease.
• Further prospective clinical trials are essential to establish the definitive role and long-term efficacy of endografts in this patient population.
• Endografting may expand endovascular treatment options for patients with extensive atherosclerosis who are poor surgical candidates.